Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft

What is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?

Hwan Hoon Chung, Mahmood K. Razavi, Daniel Y. Sze, Joan K. Frisoli, Stephen T. Kee, Michael D. Dake, Jeffrey C. Hellinger, Byung Chul Kang

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background: Inappropriately decreased portosystemic pressure gradient (PSG) during transjugular intrahepatic portosystemic shunt (TIPS) can cause fatal complications but the critical low threshold of PSG is still not clear. The aim of the present study was to evaluate the critical low threshold of PSG during TIPS. Methods: Sixty-six patients with cirrhosis who successfully underwent de novo TIPS with Viatorr stent grafts were studied. Medically uncontrolled low pressure gradient (LPR) complication was defined as when a patient died, or when acute transplantation or a TIPS reduction procedure was performed due to refractory encephalopathy or the deterioration of hepatic function within 3 months after the procedure. For the determination of the risk group for medically uncontrolled LPR complications, the Child-Pugh score and the model of end-stage liver disease (MELD) score showing a 100% negative predictive value was decided on as a threshold for each score. The risk group was defined when either of both scores was higher than its threshold. For the determination of a critical low post-TIPS PSG, a value of post-TIPS PSG showing the highest discrimination power on the receiver operating characteristic (ROC) curve in the risk group was decided on as a critical low threshold of PSG. The medically uncontrolled LPR complication rates of the patients with the determined threshold or lower were evaluated for the risk group. Results: Medically uncontrolled LPR complications developed in nine patients (13.6%). Five patients died and four patients had TIPS reduction procedures. Patients with more than 10 on the Child-Pugh score or more than 14 on the MELD score were determined to be the risk group and 34 patients were included. The critical lower threshold of the post-TIPS PSG showing the highest discrimination power on the ROC curve was 5 mmHg (sensitivity 100%, specificity 72%), and the medically uncontrolled LPR complication rates of the patients with 5 mmHg or lower on the post-TIPS PSG were 56.3% (9/16) in the risk group. Conclusions: The critical threshold of the post-TIPS PSG to avoid the medically uncontrolled LPR complications of TIPS was >5 mmHg. The PSG should not be reduced below this level in the risk group.

Original languageEnglish
Pages (from-to)95-101
Number of pages7
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume23
Issue number1
DOIs
Publication statusPublished - 2008 Jan 1

Fingerprint

Transjugular Intrahepatic Portasystemic Shunt
Stents
Transplants
Pressure
End Stage Liver Disease
ROC Curve

Keywords

  • Cirrhosis
  • Intervention
  • Liver
  • Transjugular intrahepatic portosystemic shunt

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft : What is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications? / Chung, Hwan Hoon; Razavi, Mahmood K.; Sze, Daniel Y.; Frisoli, Joan K.; Kee, Stephen T.; Dake, Michael D.; Hellinger, Jeffrey C.; Kang, Byung Chul.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 23, No. 1, 01.01.2008, p. 95-101.

Research output: Contribution to journalArticle

@article{a3cbeb9b612b4160a0a3f05ae1ab5608,
title = "Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: What is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?",
abstract = "Background: Inappropriately decreased portosystemic pressure gradient (PSG) during transjugular intrahepatic portosystemic shunt (TIPS) can cause fatal complications but the critical low threshold of PSG is still not clear. The aim of the present study was to evaluate the critical low threshold of PSG during TIPS. Methods: Sixty-six patients with cirrhosis who successfully underwent de novo TIPS with Viatorr stent grafts were studied. Medically uncontrolled low pressure gradient (LPR) complication was defined as when a patient died, or when acute transplantation or a TIPS reduction procedure was performed due to refractory encephalopathy or the deterioration of hepatic function within 3 months after the procedure. For the determination of the risk group for medically uncontrolled LPR complications, the Child-Pugh score and the model of end-stage liver disease (MELD) score showing a 100{\%} negative predictive value was decided on as a threshold for each score. The risk group was defined when either of both scores was higher than its threshold. For the determination of a critical low post-TIPS PSG, a value of post-TIPS PSG showing the highest discrimination power on the receiver operating characteristic (ROC) curve in the risk group was decided on as a critical low threshold of PSG. The medically uncontrolled LPR complication rates of the patients with the determined threshold or lower were evaluated for the risk group. Results: Medically uncontrolled LPR complications developed in nine patients (13.6{\%}). Five patients died and four patients had TIPS reduction procedures. Patients with more than 10 on the Child-Pugh score or more than 14 on the MELD score were determined to be the risk group and 34 patients were included. The critical lower threshold of the post-TIPS PSG showing the highest discrimination power on the ROC curve was 5 mmHg (sensitivity 100{\%}, specificity 72{\%}), and the medically uncontrolled LPR complication rates of the patients with 5 mmHg or lower on the post-TIPS PSG were 56.3{\%} (9/16) in the risk group. Conclusions: The critical threshold of the post-TIPS PSG to avoid the medically uncontrolled LPR complications of TIPS was >5 mmHg. The PSG should not be reduced below this level in the risk group.",
keywords = "Cirrhosis, Intervention, Liver, Transjugular intrahepatic portosystemic shunt",
author = "Chung, {Hwan Hoon} and Razavi, {Mahmood K.} and Sze, {Daniel Y.} and Frisoli, {Joan K.} and Kee, {Stephen T.} and Dake, {Michael D.} and Hellinger, {Jeffrey C.} and Kang, {Byung Chul}",
year = "2008",
month = "1",
day = "1",
doi = "10.1111/j.1440-1746.2006.04697.x",
language = "English",
volume = "23",
pages = "95--101",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft

T2 - What is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?

AU - Chung, Hwan Hoon

AU - Razavi, Mahmood K.

AU - Sze, Daniel Y.

AU - Frisoli, Joan K.

AU - Kee, Stephen T.

AU - Dake, Michael D.

AU - Hellinger, Jeffrey C.

AU - Kang, Byung Chul

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Background: Inappropriately decreased portosystemic pressure gradient (PSG) during transjugular intrahepatic portosystemic shunt (TIPS) can cause fatal complications but the critical low threshold of PSG is still not clear. The aim of the present study was to evaluate the critical low threshold of PSG during TIPS. Methods: Sixty-six patients with cirrhosis who successfully underwent de novo TIPS with Viatorr stent grafts were studied. Medically uncontrolled low pressure gradient (LPR) complication was defined as when a patient died, or when acute transplantation or a TIPS reduction procedure was performed due to refractory encephalopathy or the deterioration of hepatic function within 3 months after the procedure. For the determination of the risk group for medically uncontrolled LPR complications, the Child-Pugh score and the model of end-stage liver disease (MELD) score showing a 100% negative predictive value was decided on as a threshold for each score. The risk group was defined when either of both scores was higher than its threshold. For the determination of a critical low post-TIPS PSG, a value of post-TIPS PSG showing the highest discrimination power on the receiver operating characteristic (ROC) curve in the risk group was decided on as a critical low threshold of PSG. The medically uncontrolled LPR complication rates of the patients with the determined threshold or lower were evaluated for the risk group. Results: Medically uncontrolled LPR complications developed in nine patients (13.6%). Five patients died and four patients had TIPS reduction procedures. Patients with more than 10 on the Child-Pugh score or more than 14 on the MELD score were determined to be the risk group and 34 patients were included. The critical lower threshold of the post-TIPS PSG showing the highest discrimination power on the ROC curve was 5 mmHg (sensitivity 100%, specificity 72%), and the medically uncontrolled LPR complication rates of the patients with 5 mmHg or lower on the post-TIPS PSG were 56.3% (9/16) in the risk group. Conclusions: The critical threshold of the post-TIPS PSG to avoid the medically uncontrolled LPR complications of TIPS was >5 mmHg. The PSG should not be reduced below this level in the risk group.

AB - Background: Inappropriately decreased portosystemic pressure gradient (PSG) during transjugular intrahepatic portosystemic shunt (TIPS) can cause fatal complications but the critical low threshold of PSG is still not clear. The aim of the present study was to evaluate the critical low threshold of PSG during TIPS. Methods: Sixty-six patients with cirrhosis who successfully underwent de novo TIPS with Viatorr stent grafts were studied. Medically uncontrolled low pressure gradient (LPR) complication was defined as when a patient died, or when acute transplantation or a TIPS reduction procedure was performed due to refractory encephalopathy or the deterioration of hepatic function within 3 months after the procedure. For the determination of the risk group for medically uncontrolled LPR complications, the Child-Pugh score and the model of end-stage liver disease (MELD) score showing a 100% negative predictive value was decided on as a threshold for each score. The risk group was defined when either of both scores was higher than its threshold. For the determination of a critical low post-TIPS PSG, a value of post-TIPS PSG showing the highest discrimination power on the receiver operating characteristic (ROC) curve in the risk group was decided on as a critical low threshold of PSG. The medically uncontrolled LPR complication rates of the patients with the determined threshold or lower were evaluated for the risk group. Results: Medically uncontrolled LPR complications developed in nine patients (13.6%). Five patients died and four patients had TIPS reduction procedures. Patients with more than 10 on the Child-Pugh score or more than 14 on the MELD score were determined to be the risk group and 34 patients were included. The critical lower threshold of the post-TIPS PSG showing the highest discrimination power on the ROC curve was 5 mmHg (sensitivity 100%, specificity 72%), and the medically uncontrolled LPR complication rates of the patients with 5 mmHg or lower on the post-TIPS PSG were 56.3% (9/16) in the risk group. Conclusions: The critical threshold of the post-TIPS PSG to avoid the medically uncontrolled LPR complications of TIPS was >5 mmHg. The PSG should not be reduced below this level in the risk group.

KW - Cirrhosis

KW - Intervention

KW - Liver

KW - Transjugular intrahepatic portosystemic shunt

UR - http://www.scopus.com/inward/record.url?scp=37249056527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37249056527&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2006.04697.x

DO - 10.1111/j.1440-1746.2006.04697.x

M3 - Article

VL - 23

SP - 95

EP - 101

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 1

ER -